65.2 F
New York
Friday, May 14, 2021

-

Home Health FDA Reportedly Set To Approve Pfizer Vaccine For 12- To 15-Year-Olds

FDA Reportedly Set To Approve Pfizer Vaccine For 12- To 15-Year-Olds

Document Analysis NLP IA

404
WORDS

WORDS
2:1
Reading Time

Reading Time
positive
sentiment

Sentiment0.1689436026936
subjective
redaction

Subjectivity0.51731200897868
probably it's an affirmation
Affirmation0.26363636363636

Highlights

RELEVANT
FREQ, RAKE or TFIDF
Entity
ORG
Entity
PERSON
Entity
PRODUCT
Entity
OTHER
Key Concepts (and relevance score)

Summary (IA Generated)

The Food and Drug Administration is preparing to expand authorization for the use of the PfizerBioNTech coronavirus vaccine to children ages 12 to 15 next week, granting access to millions of young Americans, according to multiple reports.

The New York Times, citing officials familiar with the plans, first reported Monday that the FDA is set to grant the drugmakers expanded emergency use authorization, a key step in raising the country’s immunity levels that would in turn reduce the numbers of hospitalizations and deaths.

In March, Pfizer and BioNTech said clinical trial data showed their vaccine was extremely effective in children ages 12 to 15, with strong antibody responses and no serious side effects.

The companies have also begun a clinical trial into the use of the vaccine in children ages 5 to 11.

More than 147 million people have received at least one dose of a coronavirus vaccine in the United States, and about 131 million jabs have been of the Pfizer-BioNTech shot, according to the CDC.

A HuffPost Guide To Coronavirus.


131FansLike
3FollowersFollow
16FollowersFollow